The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
Web www.patentalert.com
< Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
> Piperazine derivatives and their use as therapeutic agents
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT